AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entropy Neurodynamics Limited

0.040

+0.0012.56%

Volume:7.02M

Turnover:280.48K

Market Cap:65.24M

PE:-12.89

High:0.042

Open:0.040

Low:0.039

Close:0.039

52wk High:0.046

52wk Low:0.025

Shares:1.63B

Float Shares:878.05M

Volume Ratio:8.43

T/O Rate:0.80%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.003

EPS(LYR):-0.004

ROE:-92.06%

ROA:-45.59%

PB:8.21

PE(LYR):-10.26

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Entropy Neurodynamics Seeks Trading Halt

Entropy Neurodynamics - Trading Halt Pending Announcement on US Phase 2 Clinical Trial with Prof. Robin Carhart-Harris

THOMSON REUTERS

Entropy Neurodynamics Says Strategic Agreement Signed with CDMO Biocina

Entropy Neurodynamics Executes Agreement for Manufacturing of Proprietary Therapy Candidate; Shares Up 3%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/ENP.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ENP.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","market":"AU","secType":"STK","nameCN":"Entropy Neurodynamics Limited","latestPrice":0.04,"timestamp":1787724720000,"preClose":0.039,"halted":0,"volume":7024670,"delay":0,"changeRate":0.025641025641025664,"nameEN":"Entropy Neurodynamics Limited","floatShares":878046607,"shares":1631064683,"eps":-0.003104,"marketStatus":"Closed","change":0.001,"latestTime":"08-26 16:12:00 AEST","open":0.04,"high":0.042,"low":0.039,"amount":280483,"amplitude":0.076923,"askPrice":0.041,"askSize":1554162,"bidPrice":0.039,"bidSize":1172274,"shortable":3,"etf":0,"ttmEps":-0.003104,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.039,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":8.430765,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ENP.AU","preClose":0.039,"auctionPrice":0.04,"auctionVolume":135000,"auctionTime":1787724592125,"referencePrice":0.04,"referenceTime":1787734800825,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724592125}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ENP.AU\",,,,,undefined,":{"symbol":"ENP.AU","floatShares":878046607,"roa":"-45.59%","roe":"-92.06%","lyrEps":-0.0039,"volumeRatio":8.430765,"shares":1631064683,"dividePrice":0,"high":0.042,"amplitude":0.076923,"preClose":0.039,"low":0.039,"week52Low":0.025,"pbRate":"8.21","psRate":"41.25","week52High":0.046,"institutionHeld":0,"latestPrice":0.04,"committee":-0.140069,"eps":-0.003104,"divideRate":0,"volume":7024670,"delay":0,"ttmEps":-0.003104,"open":0.04,"prevYearClose":0.033,"prevWeekClose":0.039,"prevMonthClose":0.035,"prevQuarterClose":0.032,"fiveDayClose":0.037,"twentyDayClose":0.035,"sixtyDayClose":0.033},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ENP.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ENP.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ENP.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661244254","title":"Entropy Neurodynamics Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244254?lang=en_us&edition=fundamental","pubTime":"2026-08-24 09:38","pubTimestamp":1787535481,"startTime":"0","endTime":"0","summary":"BRIEF-Entropy Neurodynamics Seeks Trading HaltAug 24 (Reuters)-Entropy Neurodynamics LtdENP.AX:TRADING HALT PENDING ANNOUNCEMENT ON US PHASE 2 CLINICAL TRIAL WITH PROF. ROBIN CARHART-HARRISFurther company coverage:ENP.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44J097:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661492392","title":"Entropy Neurodynamics - Trading Halt Pending Announcement on US Phase 2 Clinical Trial with Prof. Robin Carhart-Harris","url":"https://stock-news.laohu8.com/highlight/detail?id=2661492392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661492392?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:40","pubTimestamp":1787528412,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nFWN44J097:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660156694","title":"Entropy Neurodynamics Says Strategic Agreement Signed with CDMO Biocina","url":"https://stock-news.laohu8.com/highlight/detail?id=2660156694","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660156694?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:20","pubTimestamp":1787102427,"startTime":"0","endTime":"0","summary":"BRIEF-Entropy Neurodynamics Says Strategic Agreement Signed With CDMO BiocinaAug 19 (Reuters)-Entropy Neurodynamics LtdENP.AX:STRATEGIC AGREEMENT SIGNED WITH TGA-LICENSED, FDA- AND EMA-ALIGNED CDMO BI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44F0Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660241324","title":"Entropy Neurodynamics Executes Agreement for Manufacturing of Proprietary Therapy Candidate; Shares Up 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660241324","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660241324?lang=en_us&edition=fundamental","pubTime":"2026-08-19 09:01","pubTimestamp":1787101292,"startTime":"0","endTime":"0","summary":"Entropy Neurodynamics  executed a development and manufacturing services agreement with BioCina to manufacture its proprietary therapy candidate, TRP-8803, or IV-infused psilocin, according to a Wednesday Australian bourse filing.BioCina will conduct a program including analytical verification, engineering batch manufacture, followed by GMP placebo and active drug product batches, per the filing. The manufacturing program is expected to take 24 weeks, with real-time stability studies continuing for 24 months.Entropy is advancing TRP-8803 through a clinical program, including a 72-patient study across eight neuropsychiatric indications of high-unmet clinical need, the filing said. The agreement  provides the manufacturing capability to support clinical trials and future regulatory requirements.The company's shares climbed nearly 3% in recent trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ENP.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ENP.AU\",params:#limit:6,delay:true,,,undefined,":[]}}